Zydus Lifesciences increased its share buyback price to Rs 1,260 per share while reducing the repurchase size to 87.3 lakh shares. The total buyback outlay remains Rs 1,100 crore. The pharma stock has outperformed benchmark indices over the past one year with a 19% rally.
Market Samachar is a news aggregator. This article was originally published by Stocks-Markets-Economic Times. Tap the button above to read the full story on their site.
Trade NSE stocks with virtual coins. Build a portfolio, climb the leaderboard — zero real money.
1,500+ Indian market quiz questions. Earn coins per correct answer, climb leagues, build streaks.
Live gainers · losers · FII/DII · MTF · News Buzz. The complete Indian market dashboard.
Swipe BULL or BEAR on today's news. Earn +5 coins per swipe, +20 bonus when you're right.